Q1 2015 Holdings
Filed 2015-05-15 | 124 holdings | $155.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2015-08-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $89.8M | 1,534,000 | 57.9% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $23.0M | 289,450 | 14.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $13.5M | 3,870,824 | 8.7% |
| Amphastar Pharmaceuticals in(AMPH) | COM | 03209R103 | $6.7M | 448,532 | 4.3% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $5.2M | 150,506 | 3.4% |
| Caredx Inc(CDNA) | COM | 14167L103 | $4.5M | 804,000 | 2.9% |
| Cross Ctry Healthcare Inc(CCRN) | COM | 227483104 | $4.3M | 366,724 | 2.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $3.5M | 200,000 | 2.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.6M | 49,400 | 1.0% |
| Auspex Pharmaceuticals Inc | COM | 05211J102 | $446.1K | 4,449,103 | 0.3% |
| Horizon Pharma PLC | SHS | G4617B105 | $332.2K | 12,792,689 | 0.2% |
| Allscripts Healthcare Solutn | NOTE 1.250% 7/0 | 01988PAD0 | $98.9K | $100,750,000 | 0.1% |
| Nxstage Medical Inc | COM | 67072V103 | $87.8K | 5,073,050 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $87.2K | 11,834,595 | 0.1% |
| Avalanche Biotechnologies in | COM | 05337G107 | $85.8K | 2,117,473 | 0.1% |
| Horizon Pharma Inc | NOTE 5.000%11/1 | 44047TAB5 | $78.2K | $16,014,461 | 0.1% |
| Bluebird BIO Inc | COM | 09609G100 | $76.2K | 631,309 | 0.0% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $73.2K | 4,072,809 | 0.0% |
| Davita Healthcare Partners I(DVA) | COM | 23918K108 | $59.3K | 730,000 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $56.0K | $45,000,000 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $55.5K | 3,968,155 | 0.0% |
| Universal Amern Corp New | COM | 91338E101 | $55.4K | 5,186,148 | 0.0% |
| Integra Lifesciences Hldgs C | NOTE 1.625%12/1 | 457985AK5 | $54.6K | $47,428,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $48.9K | 631,192 | 0.0% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $43.4K | 512,800 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $41.6K | 1,050,178 | 0.0% |
| Arena Pharmaceuticals Inc | COM | 040047102 | $40.3K | 9,229,379 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $40.3K | 873,185 | 0.0% |
| Endologix Inc | COM | 29266S106 | $40.1K | 2,349,351 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $38.4K | 4,134,157 | 0.0% |
| Endologix Inc | NOTE 2.250%12/1 | 29266SAA4 | $35.2K | $34,925,000 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $33.9K | 1,628,531 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $33.1K | 363,700 | 0.0% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $32.7K | 12,078,318 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $30.6K | 3,264,588 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $30.3K | 284,300 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $29.9K | 595,443 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $29.0K | 1,895,535 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $27.7K | 2,810,164 | 0.0% |
| Accuray Inc | NOTE 3.750% 8/0 | 004397AB1 | $26.7K | $24,100,000 | 0.0% |
| Webmd Health Corp | NOTE 1.500%12/0 | 94770VAK8 | $24.4K | $23,000,000 | 0.0% |
| Heartware Intl Inc | NOTE 3.500%12/1 | 422368AA8 | $23.2K | $20,464,000 | 0.0% |
| Orthofix Intl N V | COM | N6748L102 | $22.6K | 630,222 | 0.0% |
| Alimera Sciences Inc | COM | 016259103 | $22.1K | 4,420,580 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $21.8K | 574,546 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $20.8K | 92,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $19.8K | 1,591,546 | 0.0% |
| Gilead Sciences Inc(GILD)Put | COM | 375558103 | $19.6K | 200,000 | 0.0% |
| Inogen Inc(INGN) | COM | 45780L104 | $19.3K | 601,772 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $19.0K | 606,118 | 0.0% |